137 related articles for article (PubMed ID: 38400556)
1. Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021.
Stepanishyna Y; Manni M; Civallero M; Shokun N; Skrypets T; Burtna A; Shapovalenko N; Tytorenko I; Aleksyk O; Pastushenko Y; Gubareva H; Moiseienko K; Kadnikova T; Rudyuk T; Filonenko K; Martynchyk A; Novosad O; Galli GR; Kryachok I; Federico M
Br J Haematol; 2024 May; 204(5):1757-1761. PubMed ID: 38400556
[TBL] [Abstract][Full Text] [Related]
2. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
[TBL] [Abstract][Full Text] [Related]
3. Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006.
Chihara D; Ito H; Izutsu K; Hattori M; Nishino Y; Ioka A; Matsuda T; Ito Y
Int J Cancer; 2015 Sep; 137(5):1217-23. PubMed ID: 25694231
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
6. Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.
Kriachok I; Stepanishyna Y; Skrypets T; Shokun N; Martynchyk A; Tytorenko I; Aleksik O; Krotevych M; Manni M; Federico M
Hematol Oncol; 2023 Feb; 41(1):196-200. PubMed ID: 35932211
[TBL] [Abstract][Full Text] [Related]
7. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group.
Bastos-Oreiro M; Muntañola A; Panizo C; Gonzalez-Barca E; de Villambrosia SG; Córdoba R; López JLB; González-Sierra P; Terol MJ; Gutierrez A; Grande C; Ramirez MJ; Iserte L; Perez E; Navarro B; Gomez P; Salar A; Luzardo H; López A; Del Campo R; García-Belmonte D; Vida MJ; Infante M; Queizan-Hernandez JA; Novelli S; Moreno M; Penarrubia M; Gómez J; Domingo A; Donato E; Viguria MC; López F; Rodriguez MJ; Pardal E; Noriega V; Andreu R; Peñalver J; Martín A; Caballero D; López-Guillermo A
Ann Hematol; 2020 Apr; 99(4):799-808. PubMed ID: 32076827
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Pavlovsky M; Cubero D; Agreda-Vásquez GP; Enrico A; Mela-Osorio MJ; San Sebastián JA; Fogliatto L; Ovilla R; Avendano O; Machnicki G; Barreyro P; Trufelli D; Villanova P
JCO Glob Oncol; 2022 Mar; 8():e2100265. PubMed ID: 35486884
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.
Salles G; Gopal AK; Minnema MC; Wakamiya K; Feng H; Schecter JM; Wang M
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):275-284. PubMed ID: 30795996
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma of the Eyelid - An International Multicenter Retrospective Study.
Svendsen FH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
Am J Ophthalmol; 2017 May; 177():58-68. PubMed ID: 28209503
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal lymphoproliferative disease: a series of 73 cases.
McKelvie PA; McNab A; Francis IC; Fox R; O'Day J
Clin Exp Ophthalmol; 2001 Dec; 29(6):387-93. PubMed ID: 11778809
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes.
Juntikka T; Vaittinen S; Vahlberg T; Jyrkkiö S; Minn H
Front Oncol; 2021; 11():710900. PubMed ID: 34307181
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
16. Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
Ann Hematol; 2019 May; 98(5):1169-1176. PubMed ID: 30617643
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
18. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of non-hodgkins's lymphoma with a "nodular" growth variant: a clinicopathologic study of follicular, mantle cell and marginal zone lymphomas prospectively diagnosed with multiparameter analyses.
Kadowaki I; Ichinohasama R; Sasaki O; Kimura J; Kameoka JI; Meguro K; Endo K; Tobinai K; Sasaki T; Sawai T; Ooya K
Leuk Lymphoma; 1998 Oct; 31(3-4):393-403. PubMed ID: 9869204
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
